SOMAXON PHARMACEUTICALS, INC. Retained Earnings
SOMAXON PHARMACEUTICALS, INC. had Retained Earnings of -$284.92 million as of 2012-09-30, per its 10-Q filed 2012-11-01.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2012-11-01
- 2012-09-30: Retained Earnings (Accumulated Deficit) -$284.92M.
- 2012-06-30: Retained Earnings (Accumulated Deficit) -$280.45M.
- 2012-03-31: Retained Earnings (Accumulated Deficit) -$278.25M.
- 2011-12-31: Retained Earnings (Accumulated Deficit) -$276.13M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2012-09-30 | -$284.92M 10-Q · filed 2012-11-01 |
| 2012-06-30 | -$280.45M 10-Q · filed 2012-08-08 |
| 2012-03-31 | -$278.25M 10-Q · filed 2012-05-10 |
| 2011-12-31 | -$276.13M 10-Q · filed 2012-11-01 |
| 2011-09-30 | -$265.87M 10-Q · filed 2011-11-04 |
| 2011-06-30 | -$248.84M 10-Q · filed 2011-08-03 |
| 2010-12-31 | -$216.85M 10-K · filed 2012-03-09 |